PER 3.80% 7.6¢ percheron therapeutics limited

ATL1102 US Patent - very interesting, page-22

  1. 3,236 Posts.
    lightbulb Created with Sketch. 275
    ITSA the comments come from a speaker from Westmead Hospital and she clearly mention gene therapy produced overseas so cannot be ANP
    Also if Amondys 45 is an antisense again they clearly say : gene therapy.
    ITSA you since are so friend with the guru Diamond why don’t you mention it.
    In my opinion I emphasize again it is very strange Weastmead Hospital speakers and doctors, the father are not aware of ANP/ATL1102 trial at children hospital in Melbourne and the “outstanding” results without mentioning the various worldwide scientist comments. In addition they still talk about gene therapy which lately had unfortunately for the children a great set back with Sarepta FDA failure. Mystery............
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
-0.003(3.80%)
Mkt cap ! $68.51M
Open High Low Value Volume
7.8¢ 7.8¢ 7.5¢ $47.57K 622.6K

Buyers (Bids)

No. Vol. Price($)
1 1598 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 140942 2
View Market Depth
Last trade - 16.10pm 08/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.